238 related articles for article (PubMed ID: 33634860)
1. Low positive predictive value of computed tomography screening for lung cancer irrespective of commonly employed definitions of target population.
Krilaviciute A; Brenner H
Int J Cancer; 2021 Jul; 149(1):58-65. PubMed ID: 33634860
[TBL] [Abstract][Full Text] [Related]
2. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study.
Chang GC; Chiu CH; Yu CJ; Chang YC; Chang YH; Hsu KH; Wu YC; Chen CY; Hsu HH; Wu MT; Yang CT; Chong IW; Lin YC; Hsia TC; Lin MC; Su WC; Lin CB; Lee KY; Wei YF; Lan GY; Chan WP; Wang KL; Wu MH; Tsai HH; Chian CF; Lai RS; Shih JY; Wang CL; Hsu JS; Chen KC; Chen CK; Hsia JY; Peng CK; Tang EK; Hsu CL; Chou TY; Shen WC; Tsai YH; Tsai CM; Chen YM; Lee YC; Chen HY; Yu SL; Chen CJ; Wan YL; Hsiung CA; Yang PC;
Lancet Respir Med; 2024 Feb; 12(2):141-152. PubMed ID: 38042167
[TBL] [Abstract][Full Text] [Related]
3. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
[TBL] [Abstract][Full Text] [Related]
4. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
Paci E; Puliti D; Lopes Pegna A; Carrozzi L; Picozzi G; Falaschi F; Pistelli F; Aquilini F; Ocello C; Zappa M; Carozzi FM; Mascalchi M;
Thorax; 2017 Sep; 72(9):825-831. PubMed ID: 28377492
[TBL] [Abstract][Full Text] [Related]
5. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
[TBL] [Abstract][Full Text] [Related]
7. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
8. Comparison of discrimination performance of 11 lung cancer risk models for predicting lung cancer in a prospective cohort of screening-age adults from Germany followed over 17 years.
Bhardwaj M; Schöttker B; Holleczek B; Brenner H
Lung Cancer; 2022 Dec; 174():83-90. PubMed ID: 36356492
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis on the impact of lung cancer screening by low-dose computed tomography.
Sadate A; Occean BV; Beregi JP; Hamard A; Addala T; de Forges H; Fabbro-Peray P; Frandon J
Eur J Cancer; 2020 Jul; 134():107-114. PubMed ID: 32502939
[TBL] [Abstract][Full Text] [Related]
11. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
Barbosa EJM; Yang R; Hershman M
AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
[No Abstract] [Full Text] [Related]
12. HUNCHEST-II contributes to a shift to earlier-stage lung cancer detection: final results of a nationwide screening program.
Kerpel-Fronius A; Megyesfalvi Z; Markóczy Z; Solymosi D; Csányi P; Tisza J; Kecskés A; Baranyi B; Csánky E; Dóka A; Gálffy G; Göcző K; Győry C; Horváth Z; Juhász T; Kállai Á; Kincses ZT; Király Z; Király-Incze E; Kostyál L; Kovács A; Kovács A; Kuczkó É; Makra Z; Maurovich Horvát P; Merth G; Moldoványi I; Müller V; Pápai-Székely Z; Papp D; Polgár C; Rózsa P; Sárosi V; Szalai Z; Székely A; Szuhács M; Tárnoki D; Tavaszi G; Turóczi-Kirizs R; Tóth L; Urbán L; Vaskó A; Vigh É; Dome B; Bogos K
Eur Radiol; 2024 May; 34(5):3462-3470. PubMed ID: 37921926
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of the cost-effectiveness of screening for lung cancer with low dose computed tomography.
Grover H; King W; Bhattarai N; Moloney E; Sharp L; Fuller L
Lung Cancer; 2022 Aug; 170():20-33. PubMed ID: 35700629
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial.
Balekian AA; Tanner NT; Fisher JM; Silvestri GA; Gould MK
Ann Am Thorac Soc; 2016 Sep; 13(9):1568-74. PubMed ID: 27387658
[TBL] [Abstract][Full Text] [Related]
15. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
Pastorino U; Sverzellati N; Sestini S; Silva M; Sabia F; Boeri M; Cantarutti A; Sozzi G; Corrao G; Marchianò A
Eur J Cancer; 2019 Sep; 118():142-148. PubMed ID: 31336289
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China.
Zhao Z; Wang Y; Wu W; Yang Y; Du L; Dong H
JAMA Netw Open; 2022 May; 5(5):e2213634. PubMed ID: 35608858
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
[TBL] [Abstract][Full Text] [Related]
18. Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes.
Triphuridet N; Vidhyarkorn S; Worakitsitisatorn A; Sricharunrat T; Teerayathanakul N; Auewarakul C; Chungklay N; Krongthong W; Luengingkasoot S; Sornsamdang G; Patumanond J; Sritipsukho P
Lung Cancer; 2018 Aug; 122():243-248. PubMed ID: 30032839
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
Sestini S; Boeri M; Marchiano A; Pelosi G; Galeone C; Verri C; Suatoni P; Sverzellati N; La Vecchia C; Sozzi G; Pastorino U
Oncotarget; 2015 Oct; 6(32):32868-77. PubMed ID: 26451608
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
